In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure received from Trident Lifeline Limited in terms of sub regulation (1) of said regulation.
Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 2011
View original source (BSE India)Trident Texofab Ltd. on 6ix
Story so far
Earlier from Trident Texofab
- Trident Texofab Ltd. Press Release Mar 26 2025
- Board Meeting Outcome for Separate Meeting Of Independent Directors
- Trident Texofab Ltd. Press Release Mar 22 2025
- Clarification Letter - Correction Of Typographical Error In Board Meeting Outcome Held On March 17, 2025
- Trident Texofab Ltd. Press Release Mar 20 2025
Later from Trident Texofab
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Trident Texofab Ltd. Press Release Apr 01 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Trident Texofab Ltd. Press Release Apr 11 2025
- Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held May 12, 2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab